Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Vatansever, H. Uzun, R. Gelisgen, S. Yurt, F. Kosar (Istanbul, Turkey). Diagnostic values of matrix metalloproteinase-2 and -9 in exudative pleural effusions. Eur Respir J 2009; 34: Suppl. 53, 3231

Member's Comments

No comment yet.

Related content which might interest you: The diagnostic value of matrix metalloproteinases -8 and -9 in pleural effusions Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions Source: Eur Respir J 2005; 25: 104-109 Year: 2005 Matrix metalloprotease-1 and tissue inhibitor of metalloprotease-1 levels in pleural effusions of different origins Source: Eur Respir J 2004; 24: Suppl. 48, 82s Year: 2004 Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Diagnostic yield of sl-selectin in differentiation of transudates from exudates in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Diagnostic value of lactatedehydrogenase in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002 Diagnostic value of C-reactive protein in exudative pleural effusions Source: International Congress 2019 – Clinical problems Year: 2019 Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo Source: Eur Respir J 2002; 20: 170-176 Year: 2002 Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Diagnostic value of leptin in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004 Osteopontin and matrix metalloproteinase-7 in bronchoalveolar lavage as markers of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002 Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Diagnostic approach to pleural effusions Source: Annual Congress 2008 - MP7 - Diagnostic approach to pleural effusions Year: 2008 Angiopoietin-2 levels are elevated in exudative pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005 Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Diagnostic value of serum - effusion albumin gradient in distinguishing exudative and transudative effusion Source: Eur Respir J 2002; 20: Suppl. 38, 442s Year: 2002 Diagnostic accuracy of drop-peroxide test to differentiate transudative and exudative pleural effusion Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020